News Archive: Filtered to Research

Now Viewing Category: Research Clear Filter

RFU’s Innovation and Research Park is home to the Helix 51 biomedical incubator, where Saros Therapeutics is advancing an experimental cancer immunotherapy with new National Cancer Institute funding.

Thursday — November 5

Helix 51 Company Saros Therapeutics Receives Second $2 Million Award to Advance Cancer Immunotherapy

Saros Therapeutics, part of Rosalind Franklin University’s (RFU) Helix 51 biomedical incubator,…

Rosalind Franklin University’s Innovation and Research Park, home to Helix 51 biomedical incubator and UP Oncolytics.

Thursday — October 22

Harnessing a Virus to Fight Brain Cancer: RFU receives $2.5 Million NIH Award to Advance Experimental Glioblastoma Therapy

Helix 51’s UP Oncolytics’ experimental Zika virus-based therapy for glioblastoma is moving closer…

Holly Hunsberger, PhD, has received a $3.4 million NIH grant to investigate whether hormonal changes during perimenopause contribute to women’s increased risk of Alzheimer’s disease.

Thursday — October 15

Could Menopause Hold Clues to Women's Alzheimer's Risk?

RFU researchers will investigate how hormonal changes during perimenopause affect brain circuits involved in memory…

Neuroscientist Nicole Ferrara, PhD, has been awarded a $2.3 Million NIH grant to study COVID-19’s impact on adolescent brains.

Tuesday — September 29

Neuroscientist Nicole Ferrara, PhD, Awarded $2.3 Million NIH Grant to Study COVID-19’s Impact on Adolescent Brains

Nicole Ferrara, PhD, an assistant professor and neuroscientist at Rosalind Franklin University (RFU)…

Dr. Nancy Jao’s NIH-funded research examines the health effects of menthol cigarettes on inflammation and cardiovascular health.

Thursday — September 24

Dr. Nancy Jao Recognized as 2026 Researcher to Know

Associate Professor of Psychology Nancy Jao, PhD, was named to the Illinois Science & Technology Coalition’s (ISTC)…

Narayanan (Nara) Parameswaran, PhD, MS, BVSc, will join RFU as its next executive vice president for research.

Thursday — August 27

Dr. Narayanan Parameswaran Named Executive Vice President for Research

Rosalind Franklin University announces the appointment of Narayanan (Nara) Parameswaran, PhD, MS, BVSc, as its next…

Innovation and Research Park

Friday — May 1

Helix 51 Incubator Company BLR Bio Presents Promising New Scleroderma Drug Data at International Rheumatology Meeting

BLR Bio, a company in RFU’s Helix 51 incubator, recently presented new data at the 2026 British…

Rosalind Franklin University expanded its Helix 51 bioscience incubator into its Innovation and Research Park to accommodate continued demand. The expansion added roughly 6,000 square feet of additional lab and office capacity, bringing the total footprint to just under 13,000 square feet.

Tuesday — April 7

Rosalind Franklin University Incubator Company Presents Promising Glioblastoma Therapy Data at Major Brain Cancer Conference

A novel glioblastoma therapy developed by Rosalind Franklin University Helix 51 incubator company…

Illustration depicting healthcare scenes: a doctor in a white coat with a tablet, a patient in red, a clipboard checklist, lab vials, and pedestrians.

Thursday — April 2

Keeping People Healthy in the 21st Century

Population health management is reshaping systems, environments and policies.

Abstract artwork featuring overlapping silhouettes of faces in vibrant colors like blue, green, and pink, connected by white lines and dots.

Thursday — April 2

Philosophy 007

What do a doctorate of philosophy, proteomics and human relationships have in common?

Previous Next

Previous

1 2 3 4 5